22.01.2010 • News

DSM invests in Bioprocess Control

DSM Venturing, the corporate venturing unit of Royal DSM, has announced that it has made an equity investment in Bioprocess Control, a market leader in providing advanced control technologies and services that enable the efficient design and optimal operation of biogas processes. In addition to the investment, a strategic cooperation agreement has been signed which will enable DSM and Bioprocess Control to leverage their complementary activities in the area of biogas. Financial details will not be disclosed.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.